- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06658431
Study on Music Intervention of Non-clinical College Students
The purpose of this trial is to understand whether a mindfulness-integrated volleyball team sports program can effectively intervene in the mental health of college students. The main questions it aims to answer is:
Does the music group effectively intervene in the participants' mental health levels, including indicators such as anxiety and depression?
Participants will:
Attend a music group once a week for 1.5 hours each session, for a total of 6 weeks.
Complete a psychological questionnaire every 3 weeks and a follow-up questionnaire every 2 weeks after the program concludes for twice.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100875
- Central University of Finance and Economics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants aged 16 years or older.
- Able to communicate in Mandarin and voluntarily participate in the study.
- Agree to consistently participate in each session.
Exclusion Criteria:
- Disagree to consistently participate in each mindfulness-integrated volleyball course.
- Individuals unable to commit to participating in each mindfulness-integrated volleyball course.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
90 minutes music group therapy
|
90 minutes music group therapy
|
|
No Intervention: control group
Without any intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
depression
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using GAD-7 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end), and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
anxiety
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using PHQ-9 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
perceived stress
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using PSS-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
sleep
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using ISI-7 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
positive and negative affective
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using PANAS-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
life satisfaction
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using SWLS-5 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
burnout
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using MBI-SS-15 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
emotion regulation
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using ERQ-10 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
loneliness and social anxiety
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using UCLA Scale to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
self acceptance
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using SAQ-16 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
|
perceived support
Time Frame: From enrollment to 4 weeks after the end of treatment.
|
Using MSPSS-6 to investigate the psychological variables of participants, a total of four assessments will be conducted, including T1 pre-test (before the start), with measurement time points at T2 (after 3 weeks of intervention), T3 (after 6 weeks of intervention), T4 (2 weeks after the end) and T5 (4 weeks after the end).
|
From enrollment to 4 weeks after the end of treatment.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CUFE2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.